eXpand Podcast, by Respiplus

eXpand courses
  • 0.0 (0)
  • MEDICINE
  • UPDATED BIWEEKLY

Expand Podcast by Respiplus, creators of Living Well with COPD. A podcast to bring you closer to experts in the respiratory field who will be discussing the best practices with a focus of improving the lives of people living with a chronic lung condition, such as COPD, Asthma, Pulmonary Fibrosis or Chronic Cough. Visit our learning platform for more free content, webinars and courses for healthcare professionals: www.expandcourses.com

  1. The Role of Early Diagnosis in Pulmonary Hypertension Management

    4D AGO

    The Role of Early Diagnosis in Pulmonary Hypertension Management

    Pulmonary Arterial Hypertension: Early Diagnosis and Hope for PatientsPulmonary arterial hypertension is rare, serious, and often missed. Yet with early diagnosis and coordinated care, many patients can live well for years.In Episode 3 of the RESPIPLUS podcast series, Dr. Jean Bourbeau is joined by cardiologist Dr. Nathan Brunner to discuss pulmonary arterial hypertension through a cardiology lens. The episode focuses on why early detection matters, how multidisciplinary teams improve care, and what happens when diagnosis is delayed.Dr. Brunner also shares insights from his research on healthcare access, including rural and Indigenous populations, and outlines emerging opportunities in diagnostics and therapy that may shape the future of pulmonary hypertension care in Canada.This podcast is produced by RESPIPLUS™ with support from Merck to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #pulmonaryarterialhypertension #pulmonaryhypertension

    21 min
  2. Exploring Pulmonary Hypertension in Canada: Diagnosis and Care

    FEB 12

    Exploring Pulmonary Hypertension in Canada: Diagnosis and Care

    Pulmonary Hypertension in Canada: Awareness, Diagnosis, and ProgressPulmonary hypertension remains widely misunderstood, yet early recognition can profoundly change patient outcomes. In this episode, we explore how awareness, guidelines, and multidisciplinary care are reshaping pulmonary hypertension care in Canada.About this episodeIn Episode 2 of the RESPIPLUS podcast series, Dr. Jean Bourbeau speaks with Dr. Sanjay Mehta about the realities of pulmonary hypertension and pulmonary arterial hypertension in clinical practice. The conversation unpacks why diagnosis is often delayed, how classification informs care, and why multidisciplinary expertise is essential for optimal management.Dr. Mehta also reflects on how advances in treatment have transformed survival and quality of life for many patients, while highlighting ongoing gaps in access to care, particularly for people living outside major urban centres. The episode emphasizes the role of research, guidelines, and patient advocacy in improving outcomes across Canada.This podcast is produced by RESPIPLUS™ with support from Merck to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #pulmonaryarterialhypertension #pulmonaryhypertension

    51 min
  3. Pulmonary Arterial Hypertension: A Deadly Missed Diagnosis

    FEB 5

    Pulmonary Arterial Hypertension: A Deadly Missed Diagnosis

    In this Season 6 episode, we sit down with Jamie Myrah, Executive Director of the Pulmonary Hypertension Association of Canada. Interviewed by Dr. Jean Bourbeau, Jamie explores the complexity of pulmonary hypertension with a focus on pulmonary arterial hypertension. She explains what PAH is, why it is often difficult to diagnose, and how delays affect patients emotionally and socially.From her front-line perspective, Jamie highlights gaps in the healthcare system, the impact of specialized clinics, and how patient stories fuel advocacy, research, and access to treatments. The conversation underscores the urgent need for better diagnostic tools and the power of community support for people living with this rare disease.This podcast is produced by RESPIPLUS™ with support from Merck to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #pulmonaryarterialhypertension #pulmonaryhypertension

    43 min
  4. Plasma: The Hidden Medicine That Saves Lives

    2025-09-26

    Plasma: The Hidden Medicine That Saves Lives

    In this episode, we speak with Anita Brickman, CEO of the Plasma Protein Therapeutics Association (PPTA), about the crucial and often misunderstood role of plasma-derived therapies in respiratory health. The discussion highlights how essential plasma donors are for the creation of life-saving medicines used to treat Alpha-1 Antitrypsin Deficiency (AATD) and other rare, chronic conditions. Together, we explore the rigorous global safety standards, the difference between plasma-derived therapies and traditional drugs, and the ongoing challenge of meeting the growing worldwide need for plasma donations.👇 Learn more and explore additional resources:🔹 Episode recap and resources https://chroniclungdiseases.com/en/news/understanding-patient-support-programs-in-alpha-1/🔹 Living Well with COPD – AATD Module (free) https://chroniclungdiseases.com/register🔹 Plasma Week www.plasmaweek.org 🔹 Alpha-1 www.alpha1.org🔹 PPTA Global www.PPTAGlobal.org🔹 AlphaNet Canada https://alphanetcanada.ca/🔹 Canadian Thoracic Society AATD Guidelines https://www.tandfonline.com/doi/full/10.1080/24745332.2024.2443178🔹 Learn more about Season 5 https://chroniclungdiseases.com/en/the-expand-podcast-season-5-aatd/🔹 Watch more episodes about Alpha-1 https://www.youtube.com/playlist?list=PLKERLVA6ikI5X8SabIgyphzutdp8RyKUBThis podcast is produced by RESPIPLUS™ with support from Takeda Canada to raise awareness about Alpha-1 and improve access to care across Canada.

    26 min
  5. Understanding Patient Support Programs in Alpha-1

    2025-06-19

    Understanding Patient Support Programs in Alpha-1

    In Episode 4 of Season 5 of the Expand Podcast, we sit down with Shanta Zurock, a clinical pharmacist and healthcare access expert, to explore the complex system challenges surrounding Alpha-1 Antitrypsin Deficiency (AATD) in Canada.Drawing from decades of experience in pharmaceutical care, Ms. Zurock offers a behind-the-scenes look at drug access, insurance navigation, and policy barriers that affect patients with rare diseases like AATD. This episode is a must-listen for healthcare professionals, advocates, and patients seeking to understand how the system works—and how to make it better.👇 Learn more and explore additional resources:🔹 Episode recap and resources https://chroniclungdiseases.com/en/news/understanding-patient-support-programs-in-alpha-1/🔹 Living Well with COPD – AATD Module (free) https://chroniclungdiseases.com/register🔹 Canadian Thoracic Society AATD Guidelines https://www.tandfonline.com/doi/full/10.1080/24745332.2024.2443178🔹 Learn more about Season 5 https://chroniclungdiseases.com/en/the-expand-podcast-season-5-aatd/🔹 Watch more episodes about Alpha-1 https://www.youtube.com/playlist?list=PLKERLVA6ikI5X8SabIgyphzutdp8RyKUBThis podcast is produced by RESPIPLUS™ with support from Takeda Canada to raise awareness about Alpha-1 and improve access to care across Canada.The eXpand Podcast episodes are available in english and french or with french subtitles available in the english version.Subscribe to The eXpand Podcast: • YouTube: https://bit.ly/eXpandPodcastYouTube• Apple Podcast: https://bit.ly/eXpandPodcastApple• Spotify: https://bit.ly/eXpandPodcastSpotify• Google Podcasts: https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #alpha1 #aatdAlpha-1 antitrypsin deficiency, lung disease, patient advocacy, augmentation therapy, healthcare access, chronic obstructive pulmonary disease, genetic conditions, awareness, diagnosis, treatment

    55 min
  6. MPOC et Alpha-1 : Le cheminement d’une personne atteinte

    2025-06-05

    MPOC et Alpha-1 : Le cheminement d’une personne atteinte

    Dans cet épisode touchant et inspirant, nous donnons la parole à Nathalie Roussin, qui partage son vécu avec la MPOC et la déficience en alpha-1 antitrypsine. Elle raconte les débuts de sa maladie, les défis du diagnostic, et comment elle a appris à vivre pleinement avec une maladie chronique.Ce que vous apprendrez dans cet épisode :- Le rôle du diagnostic précoce dans la gestion de la MPOC- Les bénéfices concrets de la réhabilitation pulmonaire- L’importance du soutien émotionnel et social- Comment vivre activement malgré une maladie chronique- Les conseils de Nathalie pour mieux communiquer et s’engager dans sa santé👇 Pour en savoir plus et explorer d’autres ressources :🔹 Résumé de l’épisode et ressources : https://chroniclungdiseases.com/fr/nouvelles/mpoc-et-alpha-1/🔹 Module « Bien vivre avec la MPOC – DAAT » (gratuit) : https://chroniclungdiseases.com/fr/register-fr/🔹 Lignes directrices de la Société canadienne de thoracologie sur la DAAT : https://www.tandfonline.com/doi/full/10.1080/24745332.2024.2443178🔹 En savoir plus sur la saison 5 : https://chroniclungdiseases.com/fr/le-podcast-expand-saison-5-daat/🔹 Voir plus d’épisodes sur l’Alpha-1 : https://www.youtube.com/playlist?list=PLKERLVA6ikI5X8SabIgyphzutdp8RyKUBCe balado est produit par RESPIPLUS™, avec le soutien de Takeda Canada, pour sensibiliser à la déficience en alpha-1 antitrypsine et améliorer l’accès aux soins à travers le Canada.Les épisodes du balado The eXpand Podcast sont disponibles en anglais et en français, ou avec des sous-titres français dans la version anglaise.Abonnez-vous à The eXpand Podcast :• YouTube : https://bit.ly/eXpandPodcastYouTube• Apple Podcast : https://bit.ly/eXpandPodcastApple• Spotify : https://bit.ly/eXpandPodcastSpotify• Google Podcasts : https://bit.ly/eXpandPodcastGoogle#theexpandpodcast #alpha1 #aatdDéficit en alpha-1 antitrypsine, maladie pulmonaire, défense des patients, thérapie d’augmentation, accès aux soins, maladie pulmonaire obstructive chronique, maladie génétique, sensibilisation, diagnostic, traitement

    37 min
  7. Navigating Alpha-1 Antitrypsin Deficiency: A Patient's Journey

    2025-05-29

    Navigating Alpha-1 Antitrypsin Deficiency: A Patient's Journey

    In Episode 2 of The Expand Podcast, Lee Andrew shares his journey living with Alpha-1 Antitrypsin Deficiency and emphysema. From early symptoms and delayed diagnosis to discovering treatment and embracing lifestyle changes, Lee’s story is one of resilience and empowerment. Hosted by Dr. Jean Bourbeau, this conversation highlights the importance of early detection, access to care, and self-advocacy for patients with rare diseases like AATD. This series is made possible thanks to support from Takeda Canada. 👉 Explore more: https://chroniclungdiseases.com/en/news/navigating-alpha-1-patient-journey/ #alpha-1 #aatd #respiplus

    30 min
  8. Breaking Down AATD: the Journey of Patient Advocacy in Lung Health

    2025-05-22

    Breaking Down AATD: the Journey of Patient Advocacy in Lung Health

    In our Season 5 premiere, we dive into Alpha-1 Antitrypsin Deficiency (AATD) — a rare but serious genetic condition that affects both the lungs and liver. People with AATD have a deficiency in a protein (alpha-1 antitrypsin) that normally protects lung tissue from inflammation. Without enough of this protein, individuals are at higher risk of developing lung conditions such as COPD, often at a younger age and even without a history of smoking. Despite being underdiagnosed and often misunderstood, AATD affects thousands of Canadians. Raising awareness, improving access to testing, and advocating for equitable treatment is critical — and that’s where this episode begins. Our special guest: We’re joined by Angela Diano, Executive Director of AlphaNet Canada, who brings both professional expertise and personal insight into what it means to live with a chronic condition. With decades of experience in patient advocacy, Angela has played a key role in expanding access to augmentation therapy, influencing national policy, and empowering patients to take an active role in their care. Access free resources related to this episode: https://chroniclungdiseases.com/en/news/breaking-down-aatd More about Season 5: https://chroniclungdiseases.com/en/the-expand-podcast-season-5-aatd/ This podcast series was developed with support from Takeda Canada. Together, we’re working to raise awareness and improve care for those living with Alpha-1 across the country. #aatd #theexpandpodcast Alpha-1 antitrypsin deficiency, lung disease, patient advocacy, augmentation therapy, healthcare access, chronic obstructive pulmonary disease, genetic conditions, awareness, diagnosis, treatment

    37 min
See All (35)

About

Expand Podcast by Respiplus, creators of Living Well with COPD. A podcast to bring you closer to experts in the respiratory field who will be discussing the best practices with a focus of improving the lives of people living with a chronic lung condition, such as COPD, Asthma, Pulmonary Fibrosis or Chronic Cough. Visit our learning platform for more free content, webinars and courses for healthcare professionals: www.expandcourses.com

Information